| Gene symbol | CCR5 | Synonyms | CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p21.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | C-C motif chemokine receptor 5 | ||||
| GTO ID | GTC1926 |
| Trial ID | NCT03593187 |
| Disease | HIV Infection |
| Altered gene | CCR5 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Cal-1 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | A Phase I/II Study of the Safety of CD34+ Haematopoietic Stem/Progenitor Cells and CD4+ T Lymphocytes Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct, in HIV-1 Infected Patients With High-risk Lymphoma |
| Year | 2018 |
| Country | France |
| Company sponsor | Assistance Publique - Hôpitaux de Paris |
| Other ID(s) | P 141004|2015-004453-41 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||